The Hallmarks of Predictive Oncology
Akshat Singhal(University of California San Diego), Trey Ideker(University of California San Diego), Benjamin Haibe‐Kains(Ontario Institute for Cancer Research), Emily So(University Health Network), Kay T. Yeung(University of California, San Diego), Jason I. Griffiths(City Of Hope National Medical Center), Priyanka Vasanthakumari(Argonne National Laboratory), Alexander Partin(Argonne National Laboratory), Natasha C. Koussa(Frederick National Laboratory for Cancer Research), Oleksandr Narykov(Argonne National Laboratory), Barbara A. Parker(Center for Personalized Cancer Treatment), Ryan Weil(Frederick National Laboratory for Cancer Research), Yitan Zhu(Argonne National Laboratory), Aritro Nath(Michigan State University), Farnoosh Abbas‐Aghababazadeh(University Health Network), Athmeya Jayaram(Hastings Center), Xiaoyu Zhao(University of California San Diego), Sara Jones(Frederick National Laboratory for Cancer Research), Jean‐Christophe Bélisle‐Pipon(Simon Fraser University), Sisira Kadambat Nair(University Health Network), Patrick D. Wall(Massachusetts Institute of Technology), G. Calderini(Simon Fraser University)
Cited by 11
Related Papers
Temporary Abolition of Pain in Man
|Science|1967|965
Epithelial–mesenchymal transition in tumor metastasis
|Molecular Oncology|2016|756
Reporting guidelines for human microbiome research: the STORMS checklist
|Nature Medicine|2021|466
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
|BMC Genomics|2008|406
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
|Scientific Reports|2015|326